Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Natera
Fierce Pharma
Roche touts Tecentriq biomarker win in bladder cancer
Roche's biomarker-driven adjuvant approach differs from the perioperative route taken by AstraZeneca and a Pfizer-Astellas-Merck trio.
Angus Liu
Aug 18, 2025 4:17pm
Guardant awarded $292M in false advertising suit against Natera
Nov 26, 2024 10:45am
Natera offers Invitae $52.5M for prenatal screening tests
Jan 22, 2024 10:27am
The highest paid medtech CEOs
Dec 12, 2022 3:00am
Natera launches lung DNA test for catching transplant rejections
Oct 18, 2021 11:38am
Qiagen pays $40M to work with Natera on prenatal screening tests
Mar 14, 2018 7:50am
